DEXCOM, INC.— Sankey Diagram
Annual mode · period ending 2026-03-31 · SEC EDGAR
FY2026 - Q4(Jan 26 · Feb 26 · Mar 26)
Total Assets
$6.63B
↓-1.8% -$118Mvs FY2025
Total Liabilities
$3.68B
↓-18.0% -$809Mvs FY2025
Equity
$2.96B
↑+30.5% +$690Mvs FY2025
Cash
$1.12B
↑+23.6% +$213Mvs FY2025
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $6.63B | $6.75B |
| Current Assets | $4.33B | $4.55B |
| Cash | $1.12B | $905M |
| ST Investments | $0 | $0 |
| Receivables | $1.09B | $1.16B |
| Inventory | $694M | $538M |
| Other Current | $1.43B | $1.96B |
| Non-Current Assets | $2.30B | $2.20B |
| PPE | $0 | $0 |
| Goodwill | $24M | $23M |
| Intangibles | $63M | $95M |
| Investments | $220M | $116M |
| Other Non-Current | $2.00B | $1.96B |
| Total Liab+Eq | $6.63B | $6.75B |
| Current Liab. | $2.22B | $3.04B |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $8M |
| Other CL | $2.22B | $3.03B |
| Non-Current Liab. | $1.45B | $1.45B |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $1.45B | $1.45B |
| Equity | $2.96B | $2.27B |
| Retained Earnings | $2.63B | $1.70B |
| Other Equity | $324M | $564M |
QuarterCharts · SEC EDGAR data · DXCM · Comparing FY2026 vs FY2025